Karolinska Institute, Sweden
Vascular Cell is an open access journal that publishes original research and timely reviews on recent advances in the understanding of the processes responsible for neovascularisation and pathological angiogenesis.
Being an expert in vascular biology, I feel extremely privileged and excited to serve the scientific community as one of the Editors-in-Chief of Vascular Cell. Vascular biology is one of the most exciting and fast-expanding areas in biomedical research. It covers almost all areas in medical research and has cross-disciplinary clinical implications for the treatment of most common and lethal human diseases including cancer, cardiovascular disease and metabolic disease. Our goal is to launch Vascular Cell as one of the most authoritative journals in the field of vascular biology by publishing high-quality papers across the entire vascular biology area, with particular emphasis on translational research in this area. Together with Professors Slevin and Kitajewski, I look forward to serving the scientific community by reporting your groundbreaking discoveries in this high-impact journal.
Yihai Cao, born in Shandong, China, received his medical training at the Medical School, Shandong University in 1983. 1983-1986, he received further basic and clinical training from the Chinese Academy of Medical Sciences and from the Ludwig Institute for Cancer Research, Switzerland. He obtained his Ph.D. degree in 1993 from the Karolinska Institutet, followed by a 3-yr postdoctoral training period at the Harvard Medical School, Children's Hospital (Dr. Judah Folkman´s Laboratory), Boston, Massachusetts, USA. He returned to the Karolinska Institutet in 1996 and became a full professor in 2004. He received a honorary medical degree (M.D.) from Copenhagen University, Denmark, 2006. He is currently a guest professor at the Linköping University, Sweden. He received the Fernstrom research prize. In 2010, Dr Cao received the distinguished professor award at the Karolinska Institutet. Dr. Cao also received the ERC-advanced research grant award for being the top scientist in Europe. His research interests include molecular mechanisms of pathological angiogenesis that contributes to obesity, metabolic diseases, diabetic complications, cancer, metastasis, and cardiovascular diseases, with emphasis on clinical relevance and translational research. He has published more than 160 research articles, which have been cited more than 11,000 times.